Adenosine receptor antagonists and Parkinson's disease: actions of the A2A receptor in the striatum.
Richardson
P J
PJ
Department of Pharmacology, University of Cambridge, United Kingdom.
Gubitz
A K
AK
Freeman
T C
TC
Dixon
A K
AK
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003342:Corpus Striatum / Q000378:metabolism*; D004745:Enkephalins / Q000235:genetics; D015870:Gene Expression / Q000502:physiology; D006801:Humans; D018377:Neurotransmitter Agents / Q000378:metabolism; D010300:Parkinson Disease / Q000378:metabolism*; D011498:Protein Precursors / Q000235:genetics; D058906:Purinergic P1 Receptor Agonists; D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1 / Q000502:physiology*; D013373:Substance P / Q000235:genetics; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D004745:Enkephalins; D018377:Neurotransmitter Agents; D011498:Protein Precursors; D058906:Purinergic P1 Receptor Agonists; D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1; C029992:proenkephalin; D013373:Substance P; D005680:gamma-Aminobutyric Acid; D000109:Acetylcholine